Preoperative factors associated with intraoperative maximum arterial pressures in patients with pheochromocytoma and paraganglioma: a single-center retrospective study

doi:10.21203/rs.3.rs-894894/v1

Download PDF

Research Article

Preoperative factors associated with intraoperative maximum arterial pressures in patients with pheochromocytoma and paraganglioma: a single-center retrospective study

https://doi.org/10.21203/rs.3.rs-894894/v1

This work is licensed under a CC BY 4.0 License

Version 1

posted

You are reading this latest preprint version

Surgery for pheochromocytoma and paraganglioma (PPGL) can lead to life-threatening complications, such as intraoperative hypertensive crises, even when adequate doses of preoperative α-receptor blockades are administered. The aim of this study was to identify preoperative factors associated with maximum arterial pressure (AP) during surgery in patients with PPGL. We retrospectively reviewed the cases of 61 PPGL patients who underwent surgical resection in our hospital between 2006 and 2020. The primary outcome was intraoperative maximum AP as a single index for continuous variables. The normal distribution of the results was confirmed by the Kolmogorov–Smirnov test. Simple and multiple linear regression model were used for statistical analysis. The median maximum systolic AP during surgery was 165 mmHg (interquartile range: 150–180 mmHg). Although the 24-h urinary-fractionated metanephrine (MN) and normetanephrine (NMN) (mg/day) was not normally distributed, the logarithmic representation (base = 10) of the combination of these continuous variables showed a normal distribution (p = 0.549). Log_{24 − h urinary−fractionated MN and NMN} was correlated with intraoperative maximum AP (R = 0.481, p < 0.001). Multiple regression analyses showed that diabetes mellitus (β = 15.835, standard error [SE] = 7.550, t statistic = 2.097, P = 0.040), the classic triad (β = 14.081, SE = 5.668, t statistic = 2.484, P = 0.016), and log_{24 − h urinary−fractionated MN and NMN} (β = 14.641, SE = 5.842, t statistic = 2.506, P = 0.015) were independent factors associated with intraoperative maximum AP. Patients with PPGL accompanied by diabetes mellitus, the classic triad, and high log _{24−h urinary−fractionated MN and NMN} values may be at risk for hypertensive crises during surgery regardless of whether preoperative α-receptor blockades are used. Clinicians should manage these patients more carefully and effectively.

Urology & Nephrology

PPGL

arterial pressure (AP)

metanephrine (MN)

normetanephrine (NMN)

Pheochromocytomas are catecholamine-secreting neoplasms arising from chromaffin cells of the adrenal medulla, and paraganglioma are defined as tumors arising from extra-adrenal chromaffin tissue. These catecholamine-secreting neoplasms are rare, and the incidence of pheochromocytoma and paraganglioma (PPGL) is about 0.6 cases per 100,000 person-years [1]. Excessive catecholamine secretion causes various symptoms, including hypertension (HTN) and the classic triad of palpitation (tachycardia), headache, and sweating [2]. It also presents comorbidities of diabetes mellitus (DM) or cardiovascular events.

Complete surgical resection is the definitive treatment for PPGL. However, unavoidable intraoperative manipulation of the tumor can cause catecholamine release and hypertensive crises. Therefore, surgery for PPGL has long been considered a challenging procedure [3]. In the 21st century, the mortality associated with surgery for PPGL has dramatically decreased to a rate of 0–3.0%, which has resulted from improvements in treatment, such as surgical techniques, preoperative management including α-receptor blockades, and anesthesia [2]. Regardless of these clinical efforts, surgery for PPGL can lead to intraoperative hypertensive crises, which cause life-threatening complications [4].

Although the guidelines issued by the Endocrine Society recommend preoperative α-receptor blockades as a prophylactic for all patients [5], a recent observational study showed that there was only a slight difference in maximum arterial pressure (AP) between patients who had been administered α-receptor blockades and those who had not [6]. These results are important because not only might there be asymptomatic patients who do not need preoperative α-receptor blockades but also severe patients who experience intraoperative hypertensive episodes despite adequate doses of preoperative α-receptor blockades.

In the current study, we retrospectively reviewed the clinical and operative records of patients with PPGL. Using this data set, we identified preoperative factors associated with intraoperative maximum arterial pressure (AP) in patients with PPGL who received adequate doses of preoperative α-receptor blockades.

Patient characteristics

The clinical and tumor characteristics of the PPGL patients are shown in Table 1. The median intraoperative maximum AP was 165 mmHg (interquartile ranges [IQR] : 150–180 mmHg). Of 61 patients, 18 (29.5%) had hypertensive episodes with intraoperative maximum APs above 180 mmHg. Preoperative hypertension and DM were shown in 28 (45.9%) and 9 (9.8%) patients, respectively. There were 16 (26.2%) patients exhibiting one or more of the classic triad. No postoperative complications greater than Grade 3 by the Clavien–Dindo classification were observed.

Table 1

Clinical and tumor characteristics in patients with PPGL.
Variables	n = 61
Age, years, median (IQR)	54.0 (44.0 − 65.0)
Sex, n (%)
Female	32 (52.5)
Male	29 (47.5)
BMI, kg/m², median (IQR)	21.4 (19.7 − 24.8)
ASA, n (%)
1	1 (1.6)
2	59 (96.7)
3	1 (1.6)
Cerebro-cardiovascular events, n (%)
Absent	58 (95.1)
Present	3 (4.9)
Hypertension, n (%)
Absent	33 (54.1)
Present	28 (45.9)
Diabetes mellitus, n (%)
Absent	55 (90.2)
Present	6 (9.8)
Classic triad*, n (%)
Absent (none of the symptoms)	45 (73.8)
Present (at least one of symptom)	16 (26.2)
Hereditary, n (%)
Unknown	54 (88.5)
MEN	5 (8.2)
VHL	1 (1.6)
SDH	1 (1.6)
Tumor location, n (%)
Pheochromocytoma	52 (85.2)
Paraganglioma	9 (14.8)
Type of surgery, n (%)
Laparoscopic	51 (83.6)
Open	10 (16.4)
Surgical approach, n (%)
Transperitoneal	54 (88.5)
Retroperitoneal	7 (11.5)
Tumor size, mm (IQR)	38.0 (28.0 − 52.0)
Urinary-fractionated MN in 24-h urine, mg/day (IQR)	0.32 (0.14 − 0.97)
Urinary-fractionated NMN in 24-h urine, mg/day (IQR)	1.40 (0.65 − 3.60)
Preoperative systolic blood pressure, mmHg (IQR)	120 (112 − 130)
Preoperative diastolic blood pressure, mmHg (IQR)	72 (67 − 81)
Intraoperative maximum arterial pressure, mmHg (IQR)	165 (150 − 180)
Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index; IQR, interquartile range; MEN, multiple endocrine neoplasia; MN, metanephrines; NMN, normetanephrines; PPGL; pheochromocytoma and paraganglioma; SDH, succinate dehydrogense; VHL, von Hipple–Lindau. *Palpitation (tachycardia), headache, and episode of sweating.

Relationship between preoperative blood pressure and intraoperative maximum AP

Intraoperative maximum AP showed a normal distribution (P = 0.618; Fig. 1A). Preoperative systolic blood pressure and diastolic blood pressure also showed normal distributions (P = 0.836 and P = 0.603, respectively; Fig. 1B and 1C). Neither preoperative systolic blood pressure nor diastolic blood pressure was correlated with intraoperative maximum AP (Fig. 2A and 2B).

Normal distributivity of preoperative continuous variables

Among the continuous variables of preoperative clinical factors, age, and body mass index (BMI) showed normal distributions (P = 0.976 and 0.332, respectively; Fig. 3A and 3B). However, tumor size, the 24-h urinary-fractionated metanephrine (MN), and the 24-h urinary-fractionated normetanephrine (NMN) were not normally distributed (all P < 0.01; S. Figure 1A, 1B, and 1C). The logarithmic representation (log₁₀) of these three continuous variables showed a normal distribution (P = 0.201–0.715; Fig. 3C, 3D, and 3E). Similarly, the 24-h urinary-fractionated MN and NMN was not normally distributed, but the logarithmic representation of this continuous variable also showed a normal distribution (P = 0.549; Fig. 3F).

Correlations between intraoperative maximum APs and preoperative variables

Log_{24 − h urinary−fractionated MN and NMN} was correlated with intraoperative maximum AP (R = 0.481, P < 0.001; Fig. 4). The correlation coefficient index was higher than each of log_{24 − h urinary−fractionated MN} and log_{24 − h urinary−fractionated NMN} (R = 0.204 and R = 0.412, respectively). Next, preoperative variables were investigated by linear regression analyses. Simple linear regression analyses showed that comorbidities of DM, the classic triad, and log_{24 − h urinary−fractionated MN and NMN} were significantly associated with intraoperative maximum AP (all P < 0.05; Table 2). Log_{24 − h urinary−fractionated MN and NMN} showed the highest t statistic among the preoperative variables (t statistic, 4.212). Then, multiple regression analyses showed that DM (β = 15.835, standard error [SE] = 7.550, t statistic = 2.097, P = 0.040), the classic triad (β = 14.081, SE = 5.668, t statistic = 2.484, P = 0.016), and log_{24 − h urinary−fractionated MN and NMN} (β = 14.641, SE = 5.842, t statistic, 2.506, P = 0.015) were independent factors associated with intraoperative maximum AP (Table 2).

Table 2

Simple and multiple linear regression analyses to assess the association between intraoperative maximum arterial pressure and preoperative variables in patients with PPGL.
Variable	Simple linear regression analysis
Variable	β	SE	t statistic	P value	β	SE	t statistic	P value
Age (years)	−0.111	0.173	−0.643	0.522
BMI (kg/m²)	0.613	0.706	0.868	0.389
Cerebro-cardiovascular events (absent vs. present)	−2.724	12.261	−0.222	0.825
Comorbidity of hypertension (absent vs. present)	8.416	5.209	1.616	0.112
Comorbidity of DM (absent vs. present)	17.461	8.612	2.028	0.047	15.835	7.550	2.097	0.040
Classic triad** (absent vs. present)	19.788	5.452	3.629	0.015	14.081	5.668	2.484	0.016
Type of surgery (open vs. laparoscopic)	−3.241	7.152	−0.453	0.652
Surgical approach (transperitoneal vs. retroperitoneal)	8.854	8.242	1.074	0.287
Log (tumor size, base = 10)	4.955	12.115	0.409	0.684
Log (24-h urinary-fractionated MN and NMN, base = 10)	22.765	5.404	4.212	< 0.001	14.641	5.842	2.506	0.015
Preoperative systolic blood pressure (mmHg)	−0.202	0.175	−1.155	0.253
BMI, body mass index; DM, diabetes mellitus; MN, metanephrines; NMN, normetanephrines; PPGL; pheochromocytoma and paraganglioma. Backward step-down selection was used. *Palpitation (tachycardia), headache, and episode of sweating.

The present study found that either preoperative systolic or diastolic blood pressure was basically stable when adequate doses of α-receptor blockades had been administered, and neither was correlated with intraoperative maximum AP in patients with PPGL. We also demonstrated that log _{24−h urinary−fractionated MN and NMN} was correlated with intraoperative maximum AP. In addition, log _{24−h urinary−fractionated MN and NMN}, DM, and the classic triad were independent factors associated with intraoperative maximum AP. Thus, PPGL patients with these clinical factors might be at risk for hypertensive crises during surgery regardless of preoperative α-receptor blockades.

PPGL presents with various life-threatening complications, including cerebro-cardiovascular disease, HTN, and DM. Falhammar et al. showed that HTN and DM were present in 67% and 27% of patients with PPGL, respectively [7]. Although our results showed that the incidence of these comorbidities were lower than reported (45.9% and 9.8%, respectively), in our cohort, tumor size was smaller than that of the cohort of Falhammar et al. (median tumor sizes of 38 mm vs. 49 mm). These results indicated that patients in our cohort were diagnosed relatively early, and detecting the tumor while still small might reduce the prevalence of complications associated with PPGL.

PPGL also presents with a wide spectrum of symptoms related to excessive catecholamine secretion. The classic triad, which include palpitation, headaches, and episode of sweating (the acronym PHE is reminiscent of pheochromocytoma), is valuable for screening symptoms for PPGL diagnosis. All three symptoms have specificities and sensitivities of more than 90% [8]. However, recent retrospective reports have indicated that only 17–24% of pheochromocytoma cases exhibit all three symptoms [7,9]. In our cohort, the percentage of patients exhibiting all three symptoms of the classic triad was even lower; patients exhibiting at least one of the three symptoms accounted for only 26.2% of cases. This could be because the patients in our cohort were diagnosed with PPGL relatively early, as mentioned earlier. Taken together, the results indicate that the classic triad is unreliable for modern PPGL diagnosis. However, our study revealed that the presence at least one symptom of the classic triad was associated with intraoperative maximum AP. Consequently, the presence or absence of the classic triad should be confirmed to assess the preoperative severity of PPGL, even after it has been diagnosed.

In our study, intraoperative maximum AP was a primary outcome and assessed as a continuous variable; we confirmed that it was normally distributed. To examine the association of preoperative continuous variables with intraoperative maximum AP, it was necessary to validate their distributions. Factors that might be related to tumor growth, such as tumor size or 24-h urinary-fractionated metabolism of catecholamines, did not show normal distributions. However, the logarithmic representation of these continuous variables showed normal distributions. Interestingly, the logarithmic representation of tumor markers is important in assessing the progression or stage of particular types of cancer [10, 11, 12]. Twenty-four-hour urinary-fractionated MN or NMN is used for biochemical screening but not disease progression or severity. Therefore, these values are considered important only for functional diagnosis of PPGL and evaluation of how many folds higher they are above the upper limit of normal (the cut-off value suggested by Japanese guidelines is three-fold). However, our results indicated that the 24-h urinary-fractionated metabolism of catecholamines should be evaluated as a logarithmic representation, similar to tumor markers; moreover, the logarithms of these variables were correlated with intraoperative maximum AP. Additionally, it was also indicated that evaluation of the sum of MN and NMN could reflect the severity of hormone secretion more accurately than either value alone.

Many experts, as well as Endocrine Society guidelines, continue to recommend preoperative α-receptor blockades to prevent hemodynamic instability and hypertensive crises for all patients with PPGL [5, 13]. In an observational study, Groeben et al. reported that there was no difference in the incidence of excessive hypertensive crises between pheochromocytoma patients who had been administered α-receptor blockades and those who had not [6]. They questioned whether all patients with pheochromocytoma require preoperative α-receptor blockades as prophylaxis. They also proposed that preoperative α-receptor blockades might not be mandatory for patients with low endocrine activity because of minimally invasive surgical techniques and highly effective drugs for intraoperative control of hemodynamic conditions. Unfortunately, we were not able to assess mild cases that might not require preoperative treatment. Meanwhile, our results revealed severe cases that were at risk for intraoperative hypertensive episodes regardless of preoperative α-adrenergic receptor blockers; therefore, patient selection is essential when considering precision preoperative management. We believe that PPGL patients can be divided into at least two categories: moderate and severe cases. Based on the opinion that there are some patients who would not require preoperative α-receptor blockades, mild cases can be added. Thus, there could be three categories. Adequate doses of preoperative α-receptor blockades would be expected to have an effect on moderate cases. However, preoperative α-receptor blockades alone might not be enough in severe cases, which have high levels of log _{24−h urinary−fractionated MN and NMN}, DM, or the classic triad. In these cases, additional preoperative interventions, such as metyrosine, which is catecholamine synthesis inhibitor, might help to stabilize intraoperative blood pressure.

Our results should be interpreted with caution because of several limitations. There were some ascertainment biases, which are inherent limitations of all retrospective observational analyses. Even though this study was not small compared with similar single-center studies, validation with a larger cohort would be required, mainly due to the rarity of PPGL. Also, we could not assess plasma free MN in most cases due to the system of Japanese insurance. Moreover, we were not able to decide the cut-off reference for log _{24−h urinary−fractionated MN and NMN}. To resolve these limitations, we will need to compare the accuracy of plasma free MN or urinary-fractionated MN for predicting intraoperative maximum AP in a larger cohort through a multi-center study.

Log_{24 − h urinary−fractionated MN and NMN}, DM, and the classic triad were independent factors associated with intraoperative maximum AP in patients with PPGL. Patients with these factors might be at risk for hypertensive crises during surgery regardless of preoperative α-receptor blockades. Clinicians should confirm these independent factors before surgery for PPGL and manage these patients more carefully and effectively.

Patient selection. The medical records of 66 patients with PPGL who underwent surgical resection at Kansai Medical University Hospital between September 2006 and September 2020 were retrospectively reviewed. Among these, five patients received partial adrenalectomies (adrenal-sparing surgeries) and were excluded from the analysis. Ultimately, the records of 61 patients were analyzed. All patients enrolled were identified as having pheochromocytoma from the pathological specimens.

Clinical parameters. The preoperative clinical data (sex, age, BMI, American Society of Anesthesiologists (ASA) score, comorbidity, PPGL-associated classic triad, tumor size, and 24-h urinary-fractionated MN and NMN) were analyzed. Comorbidities included cerebro-cardiovascular events, HTN, and DM. HTN was diagnosed as a systolic blood pressure of 140 mmHg or higher or diastolic blood pressure of 90 mmHg or higher without antihypertensive drugs at the time of medical examination. HTN was also defined as patients taking antihypertensive drugs. DM was diagnosed in patients taking DM-related drugs or insulin treatments. The classic triad was diagnosed in patients exhibiting at least one of the following symptoms: palpitations, headache, and episode of sweating. Tumor size was measured with preoperative computed tomography (CT) or magnetic resonance imaging (MRI). These clinical data were obtained from the patients’ medical records.

Preoperative management, surgery, and anesthesia. All patients were treated with the maximum dose of doxazosin (16 mg/day) at least 2 weeks before surgery. Patients were admitted to the hospital the day before surgery, and preoperative systolic and diastolic blood pressure was measured at rest during the daytime. Retroperitoneoscopic and laparoscopic surgical techniques have been described in detail [14]. Intraoperatively, the arterial pressure and heart rate were automatically recorded with an arterial line. Intravenous vasodilators, such as sodium nitroprusside, were administered to control undesirable increases in systolic AP. All procedures were performed by experienced surgeons and anesthesiologists at a single institution.

Statistical analysis. The primary outcome measure was intraoperative maximum AP for continuous variables. It was defined as the highest blood pressure recorded via the arterial line during surgery, excluding the time of intubation and extubation. All continuous data are shown as median values and IQRs. The normal distribution of the results was confirmed by the Kolmogorov–Smirnov test. The logarithmic representation of continuous variables was calculated with base 10. Simple and multiple linear regression analyses were performed to evaluate the relationship between intraoperative maximum APs and preoperative variables. In linear regression analysis, the t statistic, which was calculated as the ratio of an estimated coefficient (β) to its standard error, was used to test the hypothesis that a coefficient was equal to zero. All statistical analyses were performed using EZR version 1.37 [15]. A two-sided P value < 0.05 was considered statistically significant.

Ethics approval.

All procedures performed in the present study involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the institutional review board of the Kansai Medical University Hospital, Japan (Approval No. 2015607), and informed consent was obtained from all individual patients prior to surgery.

AP arterial pressure

ASA American Society of Anesthesiologists

BMI body mass index

CT computed tomography

DM diabetes mellitus

HTN hypertension

IQR interquartile range

MN metanephrine

MRI magnetic resonance imaging

NMN normetanephrine

PPGL pheochromocytoma and paraganglioma

SE standard error

Data Availability

The datasets analysed during the current study are not publicly available but are available from the corresponding author on reasonable request.

Author contributions

H Ohsugi: project development, data collection, and manuscript writing. N Takizawa: data collection, data management, and manuscript editing. T Matsuda: study supervision. H Kinoshita: manuscript editing and study supervision.

Competing interests

This research did not receive any specific grants and fellowships from any funding agency in the public, commercial or not-for-profit sector.

1. Berends AMA, Buitenwerf E, de Krijger RR, et al. Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: A nationwide study and systematic review. Eur J Intern Med. 51, 68-73 (2018).

2. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 366, 665-675 (2005).

3. Roizen MF, Schreider BD, Hassan SZ. Anesthesia for patients with pheochromocytoma. Anesthesiol Clin North America. 5, 269–75 (1987).

4. Conzo G, Musella M, Corcione F, et al. Role of preoperative adrenergic blockade with doxazosin on hemodynamic control during the surgical treatment of pheochromocytoma: a retrospective study of 48 cases. Am Surg. 79, 1196-1202 (2013).

5. Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 99, 1915-1942 (2014).

6. Groeben H, Nottebaum BJ, Alesina PF, et al. Perioperative α-receptor blockade in phaeochromocytoma surgery: an observational case series. Br J Anaesth. 118, 182-189 (2017).

7. Falhammar H, Kjellman M, Calissendorff J. Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center. Endocr Connect. 7, 186-192 (2018).

8. Plouin PF, Degoulet P, Tugayé A, Ducrocq MB, Ménard J. Le dépistage du phéochromocytome: chez quels hypertendus? Etude sémiologique chez 2585 hypertendus dont 11 ayant un phéochromocytome [Screening for phaeochromocytoma: in which hypertensive patients? A semiological study of 2585 patients, including 11 with phaeochromocytoma (author's transl)]. Nouv Presse Med. 10, 869-872 (1981).

9. Baguet JP, Hammer L, Mazzuco TL, et al. Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients. Eur J Endocrinol. 150, 681-686 (2004).

10. Laird AK. DYNAMICS OF TUMOR GROWTH. Br J Cancer. 13, 490-502 (1964).

11. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol. 15, 594-603 (1997).

12. Stein WD, Figg WD, Dahut W, et al. Tumor growth rates derived from data for patients in a clinical trial correlate strongly with patient survival: a novel strategy for evaluation of clinical trial data. Oncologist. 13, 1046-1054 (2008).

13. Neumann HPH, Young WF Jr, Eng C. Pheochromocytoma and Paraganglioma. N Engl J Med. 381, 552-565 (2019).

14. Gagner M, Pomp A, Heniford BT, Pharand D, Lacroix A. Laparoscopic adrenalectomy: lessons learned from 100 consecutive procedures. Ann Surg. 226, 238-246 (1997).

15. Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 48, 452-458 (2013).

No competing interests reported.

Download PDF

Version 1

posted

You are reading this latest preprint version

Preoperative factors associated with intraoperative maximum arterial pressures in patients with pheochromocytoma and paraganglioma: a single-center retrospective study

Status:

Version 1

Abstract

Figures

Introduction

Results

Patient characteristics

Relationship between preoperative blood pressure and intraoperative maximum AP

Normal distributivity of preoperative continuous variables

Correlations between intraoperative maximum APs and preoperative variables

Discussion

Conclusion

Methods

Abbreviations

Declarations

References

Additional Declarations

Status:

Version 1